Jadelle®: Progesterone-only implant contraception

To enable women requesting contraception and enable them to make informed choices about managing their fertility.

Jadelle^® is a long-acting reversible contraception (LARC) initially approved for use in the US in 1996.  Jadelle^®is now approved in more than 44 countries and used by more than 3 million women worldwide.

By the end of the course you will be able to:

• Advise women and men requesting contraception and enable them to make informed choices about managing their fertility.
• Appropriately consult with and assess women who wish to use the Jadelle^® implant.
• Understand the composition and pharmacokinetics of the Jadelle^® implant and potential drug interactions.
• Explain the indications and contraindications, medical eligibility criteria, advantages and disadvantages, side effects and complications of Jadelle^® implant use.
• Understand the mode of action and contraceptive efficacy of implants.
• Manage side effects of Jadelle^® including bleeding problems.
• Describe the management of an impalpable implant.

Acknowledgements

This content was created by Dr Orna McGinn, MRCGP (UK) DRCOG DFFP FRCNZGP.